Windlas Biotech Announces Board Restructuring and Independent Director Changes
Windlas Biotech Ltd 路 Change in Management 路 12 Oct 2026, 11:51 pm
Windlas Biotech Announces Board Restructuring and Independent Director Changes Windlas Biotech approved key board changes effective 12th Oct'26. Board Chairman and Independent Director Vivek Dhariwal resigned due to personal reasons and prior commitments, stepping down from the Nomination & Remuneration Committee and CSR Committee. Concurrently, the board appointed Aashish Mehra and Soni Saran Singh as Additional Independent Directors for five consecutive years, subject to shareholder approval. Mehra brings over two decades of strategy and pharma industry experience, while Singh brings over three decades of leadership across electronics manufacturing and technology sectors.
Original exchange filing (PDF)
More announcements from Windlas Biotech Ltd
- Q2 & H1 FY27 Earnings Conference Call Transcript 路 13 Nov 2026
- Recording of Conference Call 路 07 Nov 2026
- press release titled 'Windlas Biotech Limited Reports its H1 & Q2 FY27 Financial Results" 路 05 Nov 2026
- Mr. Ashok Kumar Windlass, has been appointed, as Founder President (Senior Management Personnel) of the Company, effective from November 6, 2026. 路 05 Nov 2026
- resignation of Mr. Ashok Kumar Windlass (DIN: 00011451) from the position of Whole-time Director and Director of the Company with effect from November 5, 2026 at 10.00 A.M. 路 05 Nov 2026
- Investor Presentation - Q2 & H1FY27, 路 05 Nov 2026
- Windlas Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Approval inter alia unaudited financial results for the quarter and half year ended September 30, 2026 路 05 Nov 2026
